ALNYLAM PHARMACEUTICALS INC COM USD0.01 earnings per share and revenue

0HD2 earnings per share for the last quarter are -0.52 USD whereas the estimation was -1.12 USD which accounts for 53.41% surprise. Företagets omsättning för samma period uppgår till 494.33 M USD trots den uppskattade siffran 428.01 M USD. Estimated earnings per share for the next quarter are -1.06 USD, and revenue is expected to reach 447.74 M USD. Also watch annual changes over time to get a bigger picture of 0HD2 earnings per share and revenue dynamics.